< Back to previous page
Researcher
Kim Kampen
- Disciplines:Oncology, Genetics, Molecular and cell biology, Medical biotechnology, Bioinformatics and computational biology
Affiliations
- Laboratory for Disease Mechanisms in Cancer (Division)
Member
From1 Jun 2015 → Today
Projects
1 - 5 of 5
- Contribution of serine synthesis enzyme PSPH in the pathogenesis and therapeutic resistance of T-ALLFrom1 Oct 2018 → 30 Jun 2023Funding: FWO fellowships, Foundations, funds and other with scientific goal
- Contribution of heterozygous loss of ribosomal protein L5 to glioblastoma pathogenesisFrom18 Nov 2017 → 17 Nov 2020Funding: Nonprofit institution or equivalents
- Bcl-2 inhibition as a new therapeutic opportunity for RPL10 R98S mutant pediatric T-ALLFrom2 Jun 2017 → 1 Jun 2018Funding: Foundations, funds and other with scientific goal
- Metabolic rewiring in cancer: Pharmacological targeting of serine/glycine synthesis addicted cancersFrom24 May 2017 → 15 Dec 2020Funding: Own budget, for example: patrimony, inscription fees, gifts
- Contribution of heterozygous loss of ribosomal protein L5 to glioblastoma pathogenesisFrom1 May 2017 → 30 Apr 2018Funding: BOF - Other initiatives
Publications
1 - 10 of 24
- Targeting serine/glycine metabolism improves radiotherapy response in non-small cell lung cancer (12 FEB, 10.1038/s41416-023-02553-y, 2024 )(2024)
Authors: Kim De Keersmaecker, Maarten Lambrecht, Kim Kampen
- Targeting serine/glycine metabolism improves radiotherapy response in non-small cell lung cancer(2024)
Authors: Kim De Keersmaecker, Maarten Lambrecht, Kim Kampen
Pages: 568 - 584 - Iron-responsive element of Divalent metal transporter 1 (Dmt1) controls Notch-mediated cell fates(2023)
Authors: Kim Kampen
Pages: 5811 - 5834 - Drivers of de novo Serine/Glycine synthesis in acute leukemia(2023)
Authors: Paulien Verstraete, Kim De Keersmaecker, Kim Kampen
Pages: 2145 - 2146 - Transcription factor NKX2-1 drives serine and glycine synthesis addiction in cancer(2023)
Authors: Elien Heylen, Paulien Verstraete, Linde Van Aerschot, Tom Venken, David Nittner, Anne Uyttebroeck, Heidi Segers, Diether Lambrechts, Jan Cools, Kim De Keersmaecker, et al.
Pages: 1862 - 1878 - Oncogenic drivers and therapeutic targeting of serine and glycine synthesis in cancer(2023)
Authors: Elien Heylen, Kim De Keersmaecker, Kim Kampen
- Patient-derived glioblastoma organoids reflect tumor heterogeneity and treatment sensitivity(2023)
Authors: Maxime Vanmechelen, Kim Kampen, Frederik De Smet
- Exploitation of the ribosomal protein L10 R98S mutation to enhance recombinant protein production in mammalian cells(2022)
Authors: Benno Verbelen, Paulien Verstraete, Sonia Cinque, Maya Imbrechts, Nick Geukens, Daniele Pepe, Kim Kampen, Kim De Keersmaecker
Pages: 100 - 114 - Linking Serine/Glycine Metabolism to Radiotherapy Resistance(2021)
Authors: Kim Kampen
- The ins and outs of serine and glycine metabolism in cancer(2021)
Authors: Elien Heylen, Kim De Keersmaecker, Kim Kampen
Pages: 131 - 141
Patents
1 - 3 of 3